Chemical safety testing is at a crossroads, according to researchers at Johns Hopkins Bloomberg School of Public Health. Traditional animal-based regulatory methods are increasingly seen as slow, expensive, ethically fraught, and poorly predictive of how chemicals actually affect humans. In a hypothesis and theory article published in Frontiers in Public Health on 19 November 2026, scientists from the Center for Alternatives to Animal Testing (CAAT) propose fusing two complementary concepts that have developed separately: Green Toxicology and the Human Exposome.
Green Toxicology, the researchers explain, is the toxicological arm of green chemistry. Rather than testing an existing chemical for hazards after it has been designed, it aims to "design-out" hazards at the earliest stages of innovation — before a substance ever reaches the marketplace. The approach relies on animal-free methods such as computer models, lab-grown cell systems, and microphysiological "organ-on-a-chip" platforms.
The Human Exposome, by contrast, works from the other end of the chemical lifecycle. It seeks to measure the totality of environmental exposures a person experiences over their lifetime — from pollutants in air and water to chemicals in food and consumer products — and link those exposures to health outcomes. This is a downstream, diagnostic approach that can reveal which chemicals are actually accumulating in human tissues and contributing to disease.
According to the article, these two frameworks have evolved in parallel but share a common technological backbone. Both rely on high-throughput new approach methodologies (NAMs), artificial intelligence-driven computational toxicology, and probabilistic risk assessment — a statistical approach that can integrate diverse data streams into decisions made under uncertainty.
The authors, Fenna C. M. Sillé, Alexandra Maertens, and Thomas Hartung, propose that integrating GT and HE into a single "design–monitor–redesign" loop could create a capability that neither paradigm possesses alone. Under this system, candidate chemicals would be evaluated prospectively during design using NAMs, then monitored in real-world use through exposome surveillance. Evidence of actual human exposure or harm would feed back to inform the next generation of chemical design.
"This hypothesis is testable within current knowledge," the authors write, citing prospective case studies that could measure whether exposome feedback reduces "regrettable substitutions" — the common problem of replacing a hazardous chemical with one that turns out to be equally or more dangerous — and improves the calibration of NAM-based predictions against real-world data.
The researchers emphasize that the framework is a proposal, not an implemented system. They note several key limitations and prerequisites, including the need for validated decision mechanisms, interoperability between different data systems, and clarity on evidence thresholds.
Beyond the technical architecture, the article argues that the convergence could yield economic and societal dividends. Shared research infrastructure could reduce costs, the accelerated replacement of animal testing aligns with ethical priorities, and linking safer chemical design to exposure data could advance environmental justice by identifying and protecting vulnerable communities that bear disproportionate chemical burdens.
The paper positions itself within a broader shift in environmental health science. The authors note that Environmental Science & Technology, in its 60th-anniversary reflections, has identified the human exposome and its translation into green chemistry and equitable policy as a central organizing theme for the coming decades.
For university students studying environmental health, toxicology, chemistry, or public policy, the proposal illustrates how emerging fields are converging around a shared challenge: how to regulate tens of thousands of chemicals — many poorly studied — in a way that protects human health without stifling innovation. The framework also highlights the growing role of computational and AI-driven methods in replacing animal testing, a shift that is reshaping curricula and research priorities in toxicology programs worldwide.
The article was published in Frontiers in Public Health under the section Environmental Health and Exposome, volume 14, 2026. The authors are affiliated with the Center for Alternatives to Animal Testing at Johns Hopkins University, with Hartung also holding a position at CAAT-Europe at the University of Konstanz, Germany.